Tuesday, 15 November 2016

Ampyra Helps MS Patients Not Only Walk Better, But Feel Better Too, Study Reports

Source Multiple Sclerosis News Today:

Results from a Phase 2 clinical trial showed that treatment with Ampyra (prolonged-release fampridine) brought both physical and psychological benefits to patients with multiple sclerosis (MS).  Read on.